Anesthesia protocols used to create ischemia reperfusion myocardial infarcts in swine
AA Cobo, FMS Margallo, CB Díaz… - Journal of the …, 2020 - ingentaconnect.com
The porcine ischemia-reperfusion model is one of the most commonly used for cardiology
research and for testing interventions for myocardial regeneration. In creating ischemic …
research and for testing interventions for myocardial regeneration. In creating ischemic …
Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53
ME Haywood, A Cocciolo, KF Porter… - Journal of molecular and …, 2020 - Elsevier
Aims One-third of DCM patients experience ventricular tachycardia (VT), but a clear
biological basis for this has not been established. The purpose of this study was to identify …
biological basis for this has not been established. The purpose of this study was to identify …
[HTML][HTML] Decomposing the mechanism of Qishen granules in the treatment of heart failure by a quantitative pathway analysis method
W Ren, S Gao, H Zhang, Y Ren, X Yu, W Lin, S Guo… - Molecules, 2018 - mdpi.com
Qishen granules (QSG) have beneficial therapeutic effects for heart failure, but the effects of
decomposed recipes, including Wenyang Yiqi Huoxue (WYH) and Qingre Jiedu (QJ), are …
decomposed recipes, including Wenyang Yiqi Huoxue (WYH) and Qingre Jiedu (QJ), are …
A novel method of standardized myocardial infarction in aged rabbits
The incidence of both myocardial infarction (MI) and sudden cardiac death increases with
age. Here, we describe the development of a minimally invasive large animal model of MI …
age. Here, we describe the development of a minimally invasive large animal model of MI …
[HTML][HTML] Minocycline improves cardiac function after myocardial infarction in rats by inhibiting activation of PARP-1
H Zhao, J Zhang, G Hong - Biomedicine & Pharmacotherapy, 2018 - Elsevier
To investigate whether Minocycline can protect myocardial cells after myocardial infarction
and improve myocardial remodeling through inhibiting PARP-1 activity, thus improving …
and improve myocardial remodeling through inhibiting PARP-1 activity, thus improving …
[HTML][HTML] Artificial intelligence analysis of the impact of fibrosis in arrhythmogenesis and drug response
AM Sánchez de la Nava, L Gómez-Cid… - Frontiers in …, 2022 - frontiersin.org
Background: Cardiac fibrosis has been identified as a major factor in conduction alterations
leading to atrial arrhythmias and modification of drug treatment response. Objective: To …
leading to atrial arrhythmias and modification of drug treatment response. Objective: To …
[HTML][HTML] Особенности микробиоты носовой полости у лиц, переболевших Covid-19
ВА Романов, ИВ Духанина… - Астраханский …, 2023 - cyberleninka.ru
Новая коронавирусная инфекция 2019 года сопровождается поражением ряда органов,
тканей, систем организма человека, в том числе, микробиома. Однако некоторые …
тканей, систем организма человека, в том числе, микробиома. Однако некоторые …
[HTML][HTML] Влияние процессов деградации коллагена на кардиогемодинамическое ремоделирование у больных хронической сердечной недостаточностью
ИВ Севостьянова, ЕА Полунина… - Астраханский …, 2017 - cyberleninka.ru
Изучено кардиогемодинамическое ремоделирование у 77 больных хронической
сердечной недостаточностью (с сохранной и сниженной систолической функцией) в …
сердечной недостаточностью (с сохранной и сниженной систолической функцией) в …
[图书][B] Transcriptome Signatures and Signaling Pathways in Heart Failure
ME Sweet - 2018 - search.proquest.com
Current heart failure treatment is based on targeting symptoms and left ventricle dysfunction
severity, relying on a common HF pathway paradigm to justify common treatments for HF …
severity, relying on a common HF pathway paradigm to justify common treatments for HF …